aspirin has been researched along with Infections, Helicobacter in 257 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Peptic ulcers in patients receiving aspirin are associated with Helicobacter pylori infection." | 9.51 | Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. ( Avery, A; Coupland, CAC; Crooks, C; Dumbleton, J; Hawkey, C; Hobbs, FDR; Kendrick, D; Moore, M; Morris, C; Rubin, G; Smith, M; Stevenson, D, 2022) |
| "To compare esomeprazole alone with esomeprazole plus aspirin in the treatment of aspirin-related peptic ulcers and to investigate the independent factors associated with the failure of ulcer healing." | 9.16 | Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers. ( Chen, WC; Ger, LP; Hsu, PI; Lai, KH; Lin, SY; Liu, CP; Mar, GY, 2012) |
| "Famotidine is effective in the prevention of gastric and duodenal ulcers, and erosive oesophagitis in patients taking low-dose aspirin." | 9.14 | Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. ( Bezlyak, V; McCloskey, C; Prasad, R; Taha, AS, 2009) |
| "In patients with aspirin-related peptic ulcers/erosions, high-dose famotidine therapy is inferior to pantoprazole in preventing recurrent dyspeptic or bleeding ulcers/erosions." | 9.14 | Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. ( Chan, P; Chu, WM; Kng, C; Kwan, A; Lam, KF; Lau, YK; Ling, YH; Ng, FH; Wong, BC; Wong, SY; Yuen, WC, 2010) |
| "Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear." | 7.91 | Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study. ( Lagergren, J; Santoni, G; Xie, SH; Zheng, J, 2019) |
| "To evaluate the efficacy and safety of aspirin usage for coronary heart disease (CHD) primary prevention in patients with dyslipidemia." | 7.83 | Effects of low-dose aspirin in subjects with dyslipidemia. ( Chen, J; Lou, G; Xia, Y, 2016) |
| "This survey depicts individual discrepancies in the clinical management of patients receiving NSAIDs and/or aspirin, regarding the prophylaxis of gastroduodenal ulcer disease." | 7.78 | [Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori]. ( Armbruster, S; Mann, J; Schepp, W; Schneider, AR; Schuster, T; von Römer, W, 2012) |
| "The endoscopic characteristics of gastric ulcers in patients who were using non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin (LDA) and were infected with Helicobacter pylori remain unclear." | 7.78 | Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin. ( Abe, T; Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T; Yokoyama, S, 2012) |
| "Non-steroidal anti-inflammatory drug and aspirin (here collectively called NSAIDs) use is the second most common aetiologic factor for peptic ulcer disease and a major factor for peptic ulcer complications." | 7.71 | Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. ( Färkkilä, M; Juhola, M; Mäntynen, T; Sipponen, P; Voutilainen, M, 2001) |
| "To analyse the incidence and factors influencing the occurrence of UGIB in patients taking low-dose aspirin for the prevention of cardiovascular diseases outside clinical trials." | 7.71 | Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. ( Arroyo, MT; Ferreira, IJ; Lanas, A; Serrano, P, 2002) |
| "Endoscopic oesophageal and gastro-duodenal lesions were graded in 287 patients with reflux oesophagitis, median age 57 years, including 168 with oesophageal erosions, 131 infected with, 45 patients taking aspirin 75 mg daily, and 65 patients taking simple analgesics containing paracetamol/codeine." | 7.71 | Correlation between erosive oesophageal and gastro-duodenal diseases. the influence of aspirin, simple analgesics, and Helicobacter pylori. ( Angerson, WJ; Morran, CG; Taha, AS, 2002) |
| " Our aim was to investigate whether a similar blockade of inhibitory responses could be provoked by inducing gastritis with aspirin, thus implicating a common inflammatory component, possibly a proinflammatory cytokine(s)." | 7.70 | Aspirin-induced gastritis, like Helicobacter pylori-induced gastritis disinhibits acid secretion in humans: relation to cytokine expression. ( Hamlet, A; Lindholm, C; Nilsson, O; Olbe, L, 1998) |
| "Dyspepsia in the community is linked to smoking and aspirin use, but not to H pylori infection." | 7.70 | Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. ( Hazel, S; Jones, M; Mitchell, H; Nandurkar, S; Talley, NJ; Xia, H, 1998) |
| "Current studies lack appropriate data on aspirin and other risk factors for gastrointestinal perforation." | 7.69 | Evidence of aspirin use in both upper and lower gastrointestinal perforation. ( Bajador, E; Benito, R; Esteva, F; Lanas, A; Sáinz, R; Serrano, P, 1997) |
| "Peptic ulcers in patients receiving aspirin are associated with Helicobacter pylori infection." | 5.51 | Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. ( Avery, A; Coupland, CAC; Crooks, C; Dumbleton, J; Hawkey, C; Hobbs, FDR; Kendrick, D; Moore, M; Morris, C; Rubin, G; Smith, M; Stevenson, D, 2022) |
| " pylori infection, use or abuse (often surreptitious) of high dose non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin (ASA) are the two major causes of true refractory ulcers." | 5.41 | Advances in the pharmacotherapeutic management of refractory peptic ulcers. ( Borao Laguna, C; Lanas, A, 2023) |
| "Aspirin has anti-inflammatory and antineoplastic activity." | 5.35 | Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils. ( Chan, AO; Chen, MH; Cho, CH; Gu, Q; Hu, PJ; Li, GQ; Liang, YJ; Lin, HL; Qiao, L; So, WH; Tatematsu, M; Tsukamoto, T; Wong, BC; Xia, HH; Yuen, MF, 2008) |
| " Patients with Helicobacter pylori infection and a history of peptic ulcer were assigned dual antiplatelet combination with omeprazole." | 5.17 | Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting. ( Chen, G; Du, Y; Hang, L; Ma, B, 2013) |
| "To compare esomeprazole alone with esomeprazole plus aspirin in the treatment of aspirin-related peptic ulcers and to investigate the independent factors associated with the failure of ulcer healing." | 5.16 | Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers. ( Chen, WC; Ger, LP; Hsu, PI; Lai, KH; Lin, SY; Liu, CP; Mar, GY, 2012) |
| "Famotidine is effective in the prevention of gastric and duodenal ulcers, and erosive oesophagitis in patients taking low-dose aspirin." | 5.14 | Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. ( Bezlyak, V; McCloskey, C; Prasad, R; Taha, AS, 2009) |
| "In patients with aspirin-related peptic ulcers/erosions, high-dose famotidine therapy is inferior to pantoprazole in preventing recurrent dyspeptic or bleeding ulcers/erosions." | 5.14 | Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. ( Chan, P; Chu, WM; Kng, C; Kwan, A; Lam, KF; Lau, YK; Ling, YH; Ng, FH; Wong, BC; Wong, SY; Yuen, WC, 2010) |
| "Owing to wide-spread use, low-dose aspirin (LDA) produces a substantial amount of peptic ulcer disease." | 5.01 | Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis. ( Grigg, SE; Sarri, GL; Yeomans, ND, 2019) |
| "Aspirin, even at low doses, has been known to cause upper gastro-intestinal complications, such as gastroduodenal ulcers, despite the definite benefits from its antithrombotic effects." | 4.91 | Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury. ( Iijima, K; Shimosegawa, T, 2015) |
| " pylori) infection, nonsteroidal anti-inflammatory drugs (NSAID) or low dose aspirin (ASA) use significantly and independently increased the risk for the development of peptic ulcer disease." | 4.90 | Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights. ( Gargallo, CJ; Lanas, A; Sostres, C, 2014) |
| " pylori infection and low-dose aspirin (LDA) are not only independent causal factors of peptic ulcer and gastrointestinal bleeding, they also have synergistic and additive effects." | 4.86 | [Influence of H. pylori infection on upper gastrointestinal damage]. ( Fukuzawa, M; Kawai, T; Moriyasu, F; Yamashina, A, 2010) |
| "Based on current references four clinical scenarios were discussed and different management strategies were compared for secondary and primary prophylaxis of ulcer or peptic ulcer bleeding under continuous therapy with non-steroidal antiinflammatory drugs (NSAID) or low-dose-aspirin, for H." | 4.82 | [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. ( Ittel, TH; Limmer, S; Wietholtz, H, 2003) |
| "There were no significant differences in age, sex, alcohol consumption, smoking habits, history of diabetes, hypertension, and dyslipidemia, and aspirin intake between the eradication and non-eradication groups (3783 vs." | 4.31 | Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months. ( Ahn, S; Choi, Y; Hwang, IC; Kim, N; Kim, SB; Lee, DH; Lim, SH; Park, J; Park, YS; Shin, CM; Song, DH; Yoon, H, 2023) |
| "Whether or not the use of metformin decreases the risk of gastric adenocarcinoma is unclear." | 3.91 | Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study. ( Lagergren, J; Santoni, G; Xie, SH; Zheng, J, 2019) |
| " We evaluated the effects of aspirin on genetic/epigenetic alterations in precancerous conditions, i." | 3.85 | Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer. ( Das, KM; Fukui, H; Hara, K; Ito, C; Kondo, T; Kono, T; Michigami, Y; Miwa, H; Morimoto, T; Oshima, T; Tomita, T; Tozawa, K; Watari, J; Yamasaki, T, 2017) |
| "To evaluate the efficacy and safety of aspirin usage for coronary heart disease (CHD) primary prevention in patients with dyslipidemia." | 3.83 | Effects of low-dose aspirin in subjects with dyslipidemia. ( Chen, J; Lou, G; Xia, Y, 2016) |
| "Gastroduodenal ulcer and erosion are common in Japanese patients taking low dose aspirin for cardioprotection." | 3.80 | Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. ( Goto, S; Hiraishi, H; Ikeda, Y; Okada, Y; Origasa, H; Shimada, K; Sugano, K; Uchiyama, S; Uemura, N, 2014) |
| " In the management of aspirin-related uncomplicated peptic ulcers in patients requiring antiplatelet therapies, continuing aspirin plus a powerful proton pump inhibitor is the choice of treatment." | 3.78 | New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment. ( Hsu, PI, 2012) |
| "The endoscopic characteristics of gastric ulcers in patients who were using non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin (LDA) and were infected with Helicobacter pylori remain unclear." | 3.78 | Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin. ( Abe, T; Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T; Yokoyama, S, 2012) |
| "Recent data from Western countries indicate that the aetiology of peptic ulcer disease (PUD) is changing as the prevalence of Helicobacter pylori is decreasing while the use of low-dose aspirin (LDA, ≤325 mg/day) is increasing." | 3.78 | The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. ( Hopkins, M; Jorgensen, A; Moorcroft, J; Musumba, C; Pirmohamed, M; Pritchard, DM; Sutton, L; Van Eker, D, 2012) |
| "The frequencies of hemorrhagic spots, erosions and peptic ulcers in the symptomatic clopidogrel users were 25%, 39% and 39%, respectively." | 3.78 | Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy. ( Chan, HH; Chang, SN; Hsiao, SH; Hsu, PI; Huang, HR; Lai, KH; Lin, CH; Lin, CK; Lin, KH; Liu, CP; Tsai, TJ; Tsay, FW; Wang, HM; Wang, KM; Yu, HC, 2012) |
| "This survey depicts individual discrepancies in the clinical management of patients receiving NSAIDs and/or aspirin, regarding the prophylaxis of gastroduodenal ulcer disease." | 3.78 | [Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori]. ( Armbruster, S; Mann, J; Schepp, W; Schneider, AR; Schuster, T; von Römer, W, 2012) |
| "Low-dose aspirin (ASA) has emerged as one of the most important causes of peptic ulcer bleeding in developed countries." | 3.78 | Anti-platelet therapy and managing ulcer risk. ( Chan, FK, 2012) |
| "A total of 40 patients with functional dyspepsia (20 with Helicobacter pylori-negative chronic gastritis, and 20 with Helicobacter pylori-positive chronic gastritis), and 37 Helicobacter pylori-negative long-term non-steroidal anti-inflammatory drug users (26 with aspirin, 11 with selective cyclooxygenase-2 inhibitors) were selected." | 3.78 | Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa. ( Chen, J; Chen, LZ; Chen, MH; Mao, W; Peng, TL; Yin, XF, 2012) |
| "PPI was superior to H2-receptor antagonist for prevention of peptic ulcer, and cotreatment with AT1 receptor blocker or ACE inhibitor seemed to reduce peptic ulcer among patients taking low-dose aspirin." | 3.75 | Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. ( Haruma, K; Hata, J; Imamura, H; Kamada, T; Kusunoki, H; Manabe, N; Sakakibara, T; Shiotani, A; Tarumi, K; Yamanaka, Y, 2009) |
| " The records of H pylori status (CLO-test), endoscopic findings of GU, DU and gastritis, personal habits (smoking, alcohol intake) and medication [non-steroidal anti-inflammatory drugs (NSAIDs), aspirin intake] were analyzed using multi-way frequency analysis." | 3.74 | H pylori infection and other risk factors associated with peptic ulcers in Turkish patients: a retrospective study. ( Abasiyanik, MF; Bayyurt, N; Salih, BA; Sander, E, 2007) |
| "To analyse the incidence and factors influencing the occurrence of UGIB in patients taking low-dose aspirin for the prevention of cardiovascular diseases outside clinical trials." | 3.71 | Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. ( Arroyo, MT; Ferreira, IJ; Lanas, A; Serrano, P, 2002) |
| "Endoscopic oesophageal and gastro-duodenal lesions were graded in 287 patients with reflux oesophagitis, median age 57 years, including 168 with oesophageal erosions, 131 infected with, 45 patients taking aspirin 75 mg daily, and 65 patients taking simple analgesics containing paracetamol/codeine." | 3.71 | Correlation between erosive oesophageal and gastro-duodenal diseases. the influence of aspirin, simple analgesics, and Helicobacter pylori. ( Angerson, WJ; Morran, CG; Taha, AS, 2002) |
| ", omeprazole, misoprostol, and high-dose famotidine) in the prevention of NSAID-induced gastroduodenal ulcers will also be effective in this setting." | 3.71 | Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. ( Lanas, AI, 2001) |
| "Non-steroidal anti-inflammatory drug and aspirin (here collectively called NSAIDs) use is the second most common aetiologic factor for peptic ulcer disease and a major factor for peptic ulcer complications." | 3.71 | Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. ( Färkkilä, M; Juhola, M; Mäntynen, T; Sipponen, P; Voutilainen, M, 2001) |
| " Our aim was to investigate whether a similar blockade of inhibitory responses could be provoked by inducing gastritis with aspirin, thus implicating a common inflammatory component, possibly a proinflammatory cytokine(s)." | 3.70 | Aspirin-induced gastritis, like Helicobacter pylori-induced gastritis disinhibits acid secretion in humans: relation to cytokine expression. ( Hamlet, A; Lindholm, C; Nilsson, O; Olbe, L, 1998) |
| "Dyspepsia in the community is linked to smoking and aspirin use, but not to H pylori infection." | 3.70 | Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. ( Hazel, S; Jones, M; Mitchell, H; Nandurkar, S; Talley, NJ; Xia, H, 1998) |
| "Clinical and endoscopic findings as well as Helicobacter pylori status, gastric secretion analysis, serum gastrin levels, nonsteroidal anti-inflammatory drug (NSAID) use, and objective testing of aspirin use by platelet cyclooxygenase activity were studied in 60 consecutive refractory patients with peptic ulcer and 54 matched nonrefractory controls." | 3.69 | Risk factors associated with refractory peptic ulcers. ( Esteva, F; Lanas, AI; Remacha, B; Sáinz, R, 1995) |
| "Current studies lack appropriate data on aspirin and other risk factors for gastrointestinal perforation." | 3.69 | Evidence of aspirin use in both upper and lower gastrointestinal perforation. ( Bajador, E; Benito, R; Esteva, F; Lanas, A; Sáinz, R; Serrano, P, 1997) |
| "Low-dose aspirin is widely used in patients operated on for coronary disease as secondary prevention of coronary artery occlusion." | 3.68 | Gastric changes in coronary-operated patients with low-dose aspirin. ( Kivilaakso, E; Leivonen, M; Sipponen, P, 1992) |
| "Hence, peptic ulcer is the ulcer of both the stomach and the duodenum." | 3.01 | A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer. ( Ahmed, SI; Gogoi, HK; Kashyap, A; Maut, C; Roy, AJ, 2023) |
| " pylori-positive and 10-negative subjects) with 100 mg aspirin plus 75 mg clopidogrel (AC) once-daily dosing and AC plus 20 mg famotidine twice-daily dosing (ACH)." | 2.79 | Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine. ( Furuta, T; Ichikawa, H; Iwaizumi, M; Miyajima, H; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M, 2014) |
| "pylori gastritis was present than when it was absent, despite similar degrees of gastric mucosal prostaglandin depletion." | 2.70 | Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. ( Cryer, B; Feldman, M; Go, MF; Mallat, D, 2001) |
| "Aspirin was most commonly used (43%)." | 2.69 | Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer. ( Fock, KM; Khor, JL; Machin, D; Ng, TM; Sim, CS; Tan, AL; Teo, EK, 2000) |
| " Furthermore, there is growing evidence that long-term use of aspirin decreases the risk of colorectal cancer, even at low doses." | 2.47 | Gastrointestinal effects of aspirin. ( Lanas, A; Sostres, C, 2011) |
| "Helicobacter pylori (H pylori) infection and the use of non-steroidal anti-inflammatory drugs (NSAIDs) including aspirin at any dosage and formulation represent well-established risk factors for the development of uncomplicated and complicated peptic ulcer disease accounting for the majority of such cases." | 2.43 | Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. ( Archimandritis, AJ; Papatheodoridis, GV, 2005) |
| "Aspirin has a role in the prevention of cardiovascular and cerebrovascular disease, Alzheimer's dementia and several cancers." | 2.42 | Review article: the ageing bowel and intolerance to aspirin. ( Johns, CE; May, FE; Newton, JL, 2004) |
| " Dosing should be [figure: see text] cautious in old patients, however, because of the ability of NSAIDs and coxibs to cause fluid retention, heart failure, and hypertension." | 2.41 | Gastrointestinal safety of COX-2 specific inhibitors. ( Hawkey, CJ; Jones, JI, 2001) |
| "Over 80% of recurrences are infrequent and can be treated when they occur n 20% of ulcer patients have 3 recurrences/yr, ulcer complications, or such poor health that recurrence might prove fatal." | 2.38 | Maintenance therapy for peptic ulcer--who needs it? ( McCarthy, DM, 1993) |
| "Aspirin use was associated with a frequency-, dose-, and duration-dependent reduction in GC risk after HP eradication." | 1.48 | Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study. ( Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, AYS; Wong, ICK, 2018) |
| "Dyspepsia is a common problem in the community and clinical practice with symptom(s) considered arising from the gastroduodenal region." | 1.48 | Uninvestigated dyspepsia and associated factors of patients with gastrointestinal disorders in Dessie Referral Hospital, Northeast Ethiopia. ( Demsiss, W; Seid, A; Tamir, Z, 2018) |
| "Epidemiological studies on aspirin and stomach cancer have been inconclusive." | 1.42 | Regular aspirin use and stomach cancer risk in China. ( Duan, H; Ge, J; Shen, C; Wang, Y, 2015) |
| "Once gastrointestinal hemorrhage has occurred, several studies have indicated the need to implement simpler prognostic scales than those used today." | 1.38 | [Gastrointestinal bleeding associated with NSAIDs, antiplatelet therapy and anticoagulant agent]. ( Lanas, A, 2012) |
| "The incidence of esophageal and gastric cancers was high at 5." | 1.36 | Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study. ( Kawai, T; Watanabe, M; Yamashina, A, 2010) |
| "Aspirin has anti-inflammatory and antineoplastic activity." | 1.35 | Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils. ( Chan, AO; Chen, MH; Cho, CH; Gu, Q; Hu, PJ; Li, GQ; Liang, YJ; Lin, HL; Qiao, L; So, WH; Tatematsu, M; Tsukamoto, T; Wong, BC; Xia, HH; Yuen, MF, 2008) |
| "Diclofenac and aspirin were most common NSAIDs associated with peptic ulcers in 32." | 1.33 | Frequency of NSAID induced peptic ulcer disease. ( Abid, S; Hamid, S; Islam, M; Islam, S; Jafri, W; Yakoob, J, 2006) |
| "Uninvestigated dyspepsia is common in family practice." | 1.32 | The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. ( Armstrong, D; Barkun, AN; Chakraborty, B; Chiba, N; Daniels, S; Escobedo, S; Sinclair, P; Thomson, AB; Van Zanten, SJ; White, RJ, 2003) |
| "A case-control study of stomach cancer which includes 448 cases and 610 hospital controls has been conducted in Moscow, Russia." | 1.30 | Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. ( Borisova, E; Chkhikvadze, V; Maximovitch, D; Zaridze, D, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 21 (8.17) | 18.2507 |
| 2000's | 130 (50.58) | 29.6817 |
| 2010's | 85 (33.07) | 24.3611 |
| 2020's | 21 (8.17) | 2.80 |
| Authors | Studies |
|---|---|
| Gajewski, AŁ | 1 |
| Gawrysiak, M | 1 |
| Krupa, A | 1 |
| Rechciński, T | 1 |
| Chałubiński, M | 1 |
| Gonciarz, W | 1 |
| Chmiela, M | 1 |
| Lanas, A | 22 |
| Santilli, F | 1 |
| Hawkey, C | 2 |
| Avery, A | 1 |
| Coupland, CAC | 1 |
| Crooks, C | 1 |
| Dumbleton, J | 1 |
| Hobbs, FDR | 1 |
| Kendrick, D | 1 |
| Moore, M | 1 |
| Morris, C | 1 |
| Rubin, G | 1 |
| Smith, M | 1 |
| Stevenson, D | 1 |
| Yadlapati, R | 2 |
| Roy, AJ | 2 |
| Maut, C | 2 |
| Gogoi, HK | 2 |
| Ahmed, SI | 2 |
| Kashyap, A | 2 |
| Liuzzo, G | 1 |
| Patrono, C | 1 |
| Kim, SB | 1 |
| Kim, N | 3 |
| Park, J | 1 |
| Hwang, IC | 1 |
| Lim, SH | 1 |
| Song, DH | 1 |
| Choi, Y | 1 |
| Yoon, H | 1 |
| Shin, CM | 1 |
| Park, YS | 2 |
| Lee, DH | 2 |
| Ahn, S | 1 |
| Perisetti, A | 1 |
| Sharma, P | 1 |
| Borao Laguna, C | 1 |
| Gatta, L | 1 |
| Zullo, A | 2 |
| Vaira, D | 1 |
| Watari, J | 3 |
| Tomita, T | 3 |
| Tozawa, K | 2 |
| Oshima, T | 3 |
| Fukui, H | 3 |
| Miwa, H | 3 |
| Zheng, J | 1 |
| Xie, SH | 1 |
| Santoni, G | 1 |
| Lagergren, J | 1 |
| Scheiman, JM | 4 |
| Oura, H | 1 |
| Matsumura, T | 1 |
| Kawasaki, Y | 1 |
| Okimoto, K | 1 |
| Ishikawa, K | 1 |
| Kaneko, T | 1 |
| Tokunaga, M | 1 |
| Oike, T | 1 |
| Imai, Y | 2 |
| Yokoyama, Y | 1 |
| Akizue, N | 1 |
| Maruoka, D | 1 |
| Ohta, Y | 1 |
| Saito, K | 1 |
| Nakagawa, T | 1 |
| Arai, M | 1 |
| Kato, J | 1 |
| Kato, N | 1 |
| Ahn, JY | 1 |
| Yang, HJ | 1 |
| Vasapolli, R | 1 |
| Venerito, M | 3 |
| Schirrmeister, W | 1 |
| Thon, C | 1 |
| Weigt, J | 1 |
| Wex, T | 5 |
| Malfertheiner, P | 9 |
| Link, A | 1 |
| Guo, CG | 2 |
| Zhang, F | 2 |
| Wu, JT | 1 |
| Cheung, KS | 3 |
| Li, B | 1 |
| Law, SYK | 1 |
| Leung, WK | 4 |
| Kamal, H | 1 |
| Sadr-Azodi, O | 1 |
| Engstrand, L | 2 |
| Brusselaers, N | 1 |
| Mojkowska, A | 1 |
| Gazdzinski, S | 1 |
| Fraczek, M | 1 |
| Wyleżoł, M | 1 |
| Kawasaki, K | 1 |
| Nakamura, S | 1 |
| Kurahara, K | 1 |
| Nagasue, T | 1 |
| Yanai, S | 1 |
| Harada, A | 1 |
| Yaita, H | 1 |
| Fuchigami, T | 1 |
| Matsumoto, T | 2 |
| Negovan, A | 2 |
| Iancu, M | 1 |
| Moldovan, V | 1 |
| Sàrkàny, K | 1 |
| Bataga, S | 2 |
| Mocan, S | 2 |
| Țilea, I | 1 |
| Banescu, C | 1 |
| Shan, J | 1 |
| Lei, H | 1 |
| Shi, W | 1 |
| Sun, X | 1 |
| Tang, Y | 1 |
| Ren, C | 1 |
| Michigami, Y | 1 |
| Ito, C | 1 |
| Hara, K | 1 |
| Yamasaki, T | 2 |
| Kondo, T | 2 |
| Kono, T | 1 |
| Morimoto, T | 1 |
| Das, KM | 1 |
| Seid, A | 1 |
| Tamir, Z | 1 |
| Demsiss, W | 1 |
| Chan, EW | 2 |
| Wong, AYS | 1 |
| Chen, L | 2 |
| Seto, WK | 1 |
| Wong, ICK | 1 |
| Cuzick, J | 1 |
| Dumonceau, JM | 1 |
| Hunt, RH | 3 |
| Fujishiro, M | 1 |
| Gralnek, IM | 1 |
| Campbell, HE | 1 |
| Rostom, A | 1 |
| Villanueva, C | 1 |
| Sung, JJY | 1 |
| Fukushi, K | 1 |
| Tominaga, K | 1 |
| Nagashima, K | 1 |
| Kanamori, A | 1 |
| Izawa, N | 1 |
| Kanazawa, M | 1 |
| Sasai, T | 2 |
| Hiraishi, H | 3 |
| Ng, JC | 1 |
| Yeomans, ND | 3 |
| Sostres, C | 5 |
| Luo, PJ | 1 |
| Lin, XH | 1 |
| Lin, CC | 1 |
| Luo, JC | 4 |
| Hu, HY | 1 |
| Ting, PH | 1 |
| Hou, MC | 1 |
| Sarri, GL | 1 |
| Grigg, SE | 1 |
| Pantea, M | 1 |
| Voidăzan, S | 1 |
| Macarie, M | 1 |
| Wong, IC | 1 |
| Iwamoto, J | 1 |
| Saito, Y | 1 |
| Honda, A | 1 |
| Matsuzaki, Y | 1 |
| Kawai, T | 4 |
| Fukuzawa, M | 3 |
| Moriyasu, F | 3 |
| Yamashina, A | 4 |
| Tan, VP | 1 |
| Wong, BC | 4 |
| Uemura, N | 3 |
| Sugano, K | 1 |
| Shimada, K | 1 |
| Goto, S | 1 |
| Uchiyama, S | 1 |
| Okada, Y | 1 |
| Origasa, H | 1 |
| Ikeda, Y | 1 |
| Labenz, J | 1 |
| Mousavi, M | 1 |
| Salehimarzijarani, B | 1 |
| Dadvar, Z | 1 |
| Jalalay, NY | 1 |
| Valizadeh, N | 1 |
| Sotoudeh, H | 1 |
| Zali, M | 1 |
| Kim, SG | 1 |
| Jung, HK | 2 |
| Lee, HL | 1 |
| Jang, JY | 1 |
| Lee, H | 1 |
| Kim, CG | 1 |
| Shin, WG | 1 |
| Shin, ES | 1 |
| Lee, YC | 2 |
| Charpignon, C | 1 |
| Lesgourgues, B | 1 |
| Pariente, A | 1 |
| Nahon, S | 1 |
| Pelaquier, A | 1 |
| Gatineau-Sailliant, G | 1 |
| Roucayrol, AM | 1 |
| Courillon-Mallet, A | 1 |
| Ma, B | 1 |
| Hang, L | 1 |
| Chen, G | 1 |
| Du, Y | 1 |
| Higuchi, T | 1 |
| Iwakiri, R | 2 |
| Hara, M | 2 |
| Shimoda, R | 2 |
| Sakata, Y | 1 |
| Nakayama, A | 1 |
| Nio, K | 1 |
| Yamaguchi, S | 1 |
| Yamaguchi, D | 1 |
| Watanabe, A | 1 |
| Akutagawa, T | 1 |
| Sakata, H | 2 |
| Fujimoto, K | 2 |
| Uotani, T | 1 |
| Sugimoto, M | 1 |
| Nishino, M | 1 |
| Ichikawa, H | 3 |
| Sahara, S | 1 |
| Yamade, M | 1 |
| Iwaizumi, M | 1 |
| Yamada, T | 1 |
| Osawa, S | 1 |
| Sugimoto, K | 1 |
| Umemura, K | 1 |
| Watanabe, H | 2 |
| Miyajima, H | 1 |
| Furuta, T | 1 |
| Iijima, K | 5 |
| Koike, T | 3 |
| Ara, N | 3 |
| Nakagawa, K | 1 |
| Kondo, Y | 1 |
| Uno, K | 3 |
| Hatta, W | 1 |
| Asano, N | 3 |
| Imatani, A | 2 |
| Shimosegawa, T | 5 |
| González-Pérez, A | 1 |
| Sáez, ME | 1 |
| Johansson, S | 1 |
| Nagy, P | 1 |
| García Rodríguez, LA | 1 |
| Gargallo, CJ | 2 |
| Lim, YJ | 1 |
| Hong, SJ | 1 |
| Nagata, N | 1 |
| Niikura, R | 1 |
| Sekine, K | 1 |
| Sakurai, T | 1 |
| Shimbo, T | 1 |
| Kishida, Y | 1 |
| Tanaka, S | 1 |
| Aoki, T | 1 |
| Okubo, H | 1 |
| Watanabe, K | 2 |
| Yokoi, C | 1 |
| Akiyama, J | 1 |
| Yanase, M | 1 |
| Mizokami, M | 1 |
| Rotondano, G | 1 |
| Wang, Y | 1 |
| Shen, C | 1 |
| Ge, J | 1 |
| Duan, H | 1 |
| Carrera-Lasfuentes, P | 1 |
| Benito, R | 3 |
| Roncales, P | 1 |
| Arruebo, M | 1 |
| Arroyo, MT | 2 |
| Bujanda, L | 1 |
| García-Rodríguez, LA | 1 |
| Chung, WC | 1 |
| Jeon, EJ | 1 |
| Kim, DB | 1 |
| Sung, HJ | 1 |
| Kim, YJ | 1 |
| Lim, ES | 1 |
| Kim, MA | 1 |
| Oh, JH | 1 |
| Wu, Y | 1 |
| Hu, Y | 1 |
| You, P | 1 |
| Chi, YJ | 1 |
| Zhou, JH | 1 |
| Zhang, YY | 1 |
| Liu, YL | 1 |
| Wilson, N | 1 |
| Selak, V | 1 |
| Blakely, T | 1 |
| Leung, W | 1 |
| Clarke, P | 1 |
| Jackson, R | 1 |
| Knight, J | 1 |
| Nghiem, N | 1 |
| Shim, YK | 1 |
| Lou, G | 1 |
| Chen, J | 3 |
| Xia, Y | 1 |
| Begovic, G | 1 |
| Selmani, R | 1 |
| Yanaka, A | 1 |
| Treiber, G | 6 |
| Kuester, D | 3 |
| Roessner, A | 4 |
| Mönkemüller, K | 1 |
| Vieth, M | 4 |
| Krieg, A | 1 |
| Bhatt, DL | 1 |
| Scheiman, J | 2 |
| Abraham, NS | 1 |
| Antman, EM | 1 |
| Chan, FK | 10 |
| Furberg, CD | 1 |
| Johnson, DA | 2 |
| Mahaffey, KW | 1 |
| Quigley, EM | 3 |
| Harrington, RA | 1 |
| Bates, ER | 1 |
| Bridges, CR | 1 |
| Eisenberg, MJ | 1 |
| Ferrari, VA | 1 |
| Hlatky, MA | 1 |
| Kaul, S | 1 |
| Lindner, JR | 1 |
| Moliterno, DJ | 1 |
| Mukherjee, D | 1 |
| Schofield, RS | 1 |
| Rosenson, RS | 1 |
| Stein, JH | 1 |
| Weitz, HH | 1 |
| Wesley, DJ | 1 |
| Vestergård, A | 1 |
| Bredahl, K | 1 |
| de Muckadell, OB | 1 |
| Pedersen, OB | 1 |
| Hansen, JM | 1 |
| Nardulli, G | 1 |
| Tahara, T | 1 |
| Shibata, T | 1 |
| Nakamura, M | 1 |
| Yamashita, H | 1 |
| Yoshioka, D | 1 |
| Okubo, M | 1 |
| Maruyama, N | 1 |
| Kamano, T | 1 |
| Kamiya, Y | 1 |
| Fujita, H | 1 |
| Nagasaka, M | 1 |
| Iwata, M | 1 |
| Takahama, K | 1 |
| Watanabe, M | 3 |
| Hirata, I | 1 |
| Arisawa, T | 1 |
| Shiotani, A | 2 |
| Sakakibara, T | 2 |
| Yamanaka, Y | 2 |
| Imamura, H | 2 |
| Tarumi, K | 2 |
| Manabe, N | 1 |
| Kamada, T | 2 |
| Kusunoki, H | 1 |
| Hata, J | 2 |
| Haruma, K | 2 |
| Sung, JJ | 5 |
| Kuipers, EJ | 2 |
| El-Serag, HB | 1 |
| Lanza, FL | 2 |
| Dai, X | 1 |
| Makaryus, AN | 1 |
| Makaryus, JN | 1 |
| Jauhar, R | 1 |
| Hermansson, M | 1 |
| Ekedahl, A | 1 |
| Ranstam, J | 1 |
| Zilling, T | 1 |
| Nakayama, M | 1 |
| Ootani, H | 1 |
| Tsunada, S | 1 |
| Chiu, PW | 1 |
| Ng, EK | 1 |
| Leong, RW | 1 |
| Hawkey, CJ | 8 |
| Taha, AS | 2 |
| McCloskey, C | 1 |
| Prasad, R | 1 |
| Bezlyak, V | 1 |
| Gil, J | 1 |
| Wojtuń, S | 1 |
| Nayeb-Hashemi, H | 1 |
| Kaunitz, JD | 1 |
| Yang, P | 1 |
| Zhou, Y | 1 |
| Chen, B | 1 |
| Wan, HW | 1 |
| Jia, GQ | 1 |
| Bai, HL | 1 |
| Wu, XT | 1 |
| McColl, KE | 1 |
| Chang, FY | 2 |
| Chen, TS | 2 |
| Ng, YY | 1 |
| Lin, HC | 1 |
| Lu, CL | 1 |
| Chen, CY | 1 |
| Lin, HY | 1 |
| Lee, SD | 1 |
| Hart, J | 1 |
| Naesdal, J | 1 |
| Talley, NJ | 4 |
| Thomson, AB | 2 |
| Ng, FH | 1 |
| Wong, SY | 1 |
| Lam, KF | 1 |
| Chu, WM | 1 |
| Chan, P | 1 |
| Ling, YH | 1 |
| Kng, C | 1 |
| Yuen, WC | 1 |
| Lau, YK | 1 |
| Kwan, A | 1 |
| Lee, JH | 2 |
| Jeon, SW | 1 |
| Kim, JW | 2 |
| Lee, SW | 1 |
| Gargallo, C | 1 |
| Görgens, D | 1 |
| Langner, C | 1 |
| Sbrozzi-Vanni, A | 1 |
| Di Giulio, E | 1 |
| Hassan, C | 1 |
| Corleto, VD | 1 |
| Lahner, E | 1 |
| Annibale, B | 1 |
| Cho, DK | 1 |
| Park, SY | 1 |
| Kee, WJ | 1 |
| Ki, HS | 1 |
| Yoon, KW | 1 |
| Cho, SB | 1 |
| Lee, WS | 1 |
| Joo, YE | 1 |
| Kim, HS | 1 |
| Choi, SK | 1 |
| Rew, JS | 1 |
| Pilotto, A | 3 |
| Franceschi, M | 3 |
| Maggi, S | 1 |
| Addante, F | 1 |
| Sancarlo, D | 1 |
| Nomura, M | 1 |
| Nishi, R | 1 |
| Fletcher, EH | 1 |
| Johnston, DE | 1 |
| Fisher, CR | 1 |
| Koerner, RJ | 1 |
| Newton, JL | 2 |
| Gray, CS | 1 |
| Kim, JJ | 1 |
| Lee, BH | 1 |
| Kang, JM | 1 |
| Seo, P | 1 |
| Lim, MK | 1 |
| Kwon, JH | 1 |
| Song, BJ | 1 |
| Lee, JW | 1 |
| Lee, SH | 1 |
| Hwang, JH | 1 |
| Jeong, SH | 1 |
| Jung, HC | 1 |
| Song, IS | 1 |
| Kato, M | 1 |
| Ono, S | 1 |
| Yoshida, T | 1 |
| Mabe, K | 1 |
| Shimizu, Y | 1 |
| Asaka, M | 1 |
| Abe, Y | 2 |
| Iwai, W | 1 |
| Ohara, S | 1 |
| Bae, SE | 1 |
| Kim, SE | 1 |
| Jung, SA | 1 |
| Yoon, SY | 1 |
| Shim, KN | 1 |
| Kim, TH | 1 |
| Yoo, K | 1 |
| Moon, IH | 1 |
| Furukawa, M | 1 |
| Fujita, M | 1 |
| Takinishi, A | 1 |
| Misaka, R | 1 |
| Nagahara, H | 1 |
| Gokturk, HS | 1 |
| Demir, M | 1 |
| Unler, GK | 1 |
| Erbayrak, M | 1 |
| Sakalli, M | 1 |
| Yilmaz, U | 1 |
| Bor, S | 1 |
| Dağli, U | 1 |
| Sarer, B | 1 |
| Gürel, S | 1 |
| Tözün, N | 2 |
| Sıvrı, B | 1 |
| Akbaş, T | 1 |
| Sahın, B | 1 |
| Memık, F | 1 |
| Batur, Y | 1 |
| Hsu, PI | 3 |
| Kim, Y | 1 |
| Yokoyama, S | 1 |
| Hori, K | 1 |
| Okugawa, T | 1 |
| Toyoshima, F | 1 |
| Sakurai, J | 1 |
| Tanaka, J | 1 |
| Abe, T | 1 |
| Tomiyama, H | 1 |
| Liu, CP | 2 |
| Chen, WC | 1 |
| Lai, KH | 2 |
| Mar, GY | 1 |
| Lin, SY | 1 |
| Ger, LP | 1 |
| Valkhoff, VE | 1 |
| Sturkenboom, MC | 1 |
| Leung Ki, EL | 1 |
| Iwabuchi, T | 1 |
| Shinkai, H | 1 |
| Endo, H | 1 |
| Musumba, C | 1 |
| Jorgensen, A | 1 |
| Sutton, L | 1 |
| Van Eker, D | 1 |
| Moorcroft, J | 1 |
| Hopkins, M | 1 |
| Pritchard, DM | 1 |
| Pirmohamed, M | 1 |
| Goh, KL | 2 |
| Chan, WK | 1 |
| Mao, W | 1 |
| Peng, TL | 1 |
| Yin, XF | 1 |
| Chen, LZ | 1 |
| Chen, MH | 2 |
| Calvet, X | 1 |
| Gisbert, JP | 1 |
| Schneider, AR | 1 |
| Armbruster, S | 1 |
| Mann, J | 1 |
| von Römer, W | 1 |
| Schuster, T | 1 |
| Schepp, W | 1 |
| Tsai, TJ | 1 |
| Lin, CK | 1 |
| Chan, HH | 1 |
| Yu, HC | 1 |
| Wang, HM | 1 |
| Lin, KH | 1 |
| Wang, KM | 1 |
| Chang, SN | 1 |
| Hsiao, SH | 1 |
| Huang, HR | 1 |
| Lin, CH | 1 |
| Tsay, FW | 1 |
| Ching, JY | 1 |
| Suen, BY | 2 |
| Tse, YK | 1 |
| Wu, JC | 2 |
| Müller, H | 1 |
| Stolte, M | 1 |
| Serrano, P | 3 |
| Ferreira, IJ | 1 |
| Maiden, LP | 1 |
| Harris, AW | 1 |
| Angerson, WJ | 1 |
| Morran, CG | 1 |
| Guda, N | 1 |
| Vakil, N | 1 |
| Wepner, U | 1 |
| Shah, AA | 1 |
| Byrne, MF | 1 |
| Cullen, L | 1 |
| Walsh, T | 1 |
| Fitzgerald, DJ | 1 |
| Murray, FE | 2 |
| Monés Xiol, J | 1 |
| Lehmann, FS | 1 |
| Gyr, N | 1 |
| Thiéfin, G | 3 |
| Wardi, J | 1 |
| Shirin, H | 1 |
| McKeogh, DF | 1 |
| Barkun, AN | 1 |
| Armstrong, D | 1 |
| Chiba, N | 1 |
| White, RJ | 1 |
| Daniels, S | 1 |
| Escobedo, S | 1 |
| Chakraborty, B | 1 |
| Sinclair, P | 1 |
| Van Zanten, SJ | 1 |
| Limmer, S | 1 |
| Ittel, TH | 1 |
| Wietholtz, H | 1 |
| Kaffes, A | 1 |
| Cullen, J | 1 |
| Mitchell, H | 2 |
| Katelaris, PH | 1 |
| Hirschowitz, BI | 2 |
| Füessl, HS | 2 |
| Johns, CE | 1 |
| May, FE | 1 |
| Schwabe, M | 1 |
| Ammon, S | 1 |
| Walker, S | 1 |
| Klotz, U | 1 |
| Bazzoli, F | 2 |
| Chaussade, S | 1 |
| Abitbol, V | 1 |
| Graham, DY | 3 |
| Singh, G | 1 |
| Giral, A | 1 |
| Ozdogan, O | 1 |
| Celikel, CA | 1 |
| Ulusoy, NB | 1 |
| Kalayci, C | 1 |
| Leandro, G | 2 |
| Longo, MG | 1 |
| Perri, F | 1 |
| Scarcelli, C | 2 |
| Jolly, D | 1 |
| Czernichow, P | 1 |
| Merle, V | 1 |
| Koop, H | 1 |
| van Oijen, MG | 1 |
| Laheij, RJ | 2 |
| Peters, WH | 1 |
| Jansen, JB | 2 |
| Verheugt, FW | 2 |
| Longoa, MG | 1 |
| Orsitto, G | 1 |
| Perri, FC | 1 |
| D'Ambrosio, LP | 1 |
| Konturek, PC | 4 |
| Kania, J | 2 |
| Gessner, U | 1 |
| Konturek, SJ | 6 |
| Hahn, EG | 3 |
| Konturek, JW | 7 |
| Arkkila, PE | 1 |
| Seppälä, K | 1 |
| Kosunen, TU | 1 |
| Sipponen, P | 3 |
| Mäkinen, J | 1 |
| Rautelin, H | 1 |
| Färkkilä, M | 2 |
| Bobrzyński, A | 1 |
| Płonka, M | 1 |
| Bielański, W | 1 |
| Karcz, D | 1 |
| Park, SH | 1 |
| Park, DI | 1 |
| Kim, SH | 1 |
| Kim, HJ | 1 |
| Cho, YK | 1 |
| Sung, IK | 1 |
| Sohn, CI | 1 |
| Jeon, WK | 1 |
| Kim, BI | 1 |
| Keum, DK | 1 |
| Nakashima, S | 1 |
| Arai, S | 1 |
| Mizuno, Y | 1 |
| Yoshino, K | 1 |
| Ando, S | 1 |
| Nakamura, Y | 3 |
| Sugawara, K | 1 |
| Koike, M | 1 |
| Saito, E | 1 |
| Naito, M | 1 |
| Nakao, M | 1 |
| Ito, H | 2 |
| Hamaoka, K | 1 |
| Rai, F | 1 |
| Asakura, Y | 1 |
| Akamatu, M | 1 |
| Fujimori, K | 1 |
| Inao, M | 1 |
| Ota, S | 2 |
| Fujiwara, K | 1 |
| Shiibashi, M | 1 |
| Papatheodoridis, GV | 1 |
| Archimandritis, AJ | 1 |
| Ebert, MP | 1 |
| Schäfer, C | 1 |
| Hoffmann, J | 1 |
| Gu, P | 1 |
| Kubisch, C | 1 |
| Carl-McGrath, S | 1 |
| Röcken, C | 1 |
| Rossini, R | 1 |
| Lucà, MG | 1 |
| Scuri, P | 1 |
| Invernizzi, P | 1 |
| Strazzabosco, M | 1 |
| Gavazzi, A | 1 |
| Nakajima, S | 1 |
| Bamba, H | 1 |
| Ye, S | 1 |
| Yuan, Y | 1 |
| Padol, IT | 1 |
| Chey, WD | 1 |
| Eswaren, S | 1 |
| Howden, CW | 1 |
| Inadomi, JM | 1 |
| Fendrick, AM | 1 |
| Agustí-Escasany, A | 1 |
| Vallano-Ferraz, A | 1 |
| Fass, R | 1 |
| Modlin, IM | 1 |
| Malagelada, JR | 1 |
| Moss, SF | 1 |
| Holtmann, G | 2 |
| Katelaris, P | 1 |
| Stanghellini, V | 1 |
| Tytgat, GN | 1 |
| Wright, NA | 1 |
| Di Mario, F | 1 |
| Hamid, S | 1 |
| Yakoob, J | 1 |
| Jafri, W | 1 |
| Islam, S | 1 |
| Abid, S | 1 |
| Islam, M | 1 |
| Ji, KY | 1 |
| Hu, FL | 1 |
| Ferrandez, A | 1 |
| Stiefelhagen, P | 1 |
| Becker, JC | 1 |
| Domschke, W | 6 |
| Pohle, T | 1 |
| Yilmaz, S | 1 |
| Bayan, K | 1 |
| Dursun, M | 1 |
| Canoruç, F | 1 |
| Kilinç, N | 1 |
| Tüzün, Y | 1 |
| Daniş, R | 1 |
| Ertem, M | 1 |
| Ferrara, M | 1 |
| Coppola, L | 1 |
| Coppola, A | 1 |
| Capozzi, L | 1 |
| Salih, BA | 1 |
| Abasiyanik, MF | 1 |
| Bayyurt, N | 1 |
| Sander, E | 1 |
| Fabijanic, D | 1 |
| Banic, M | 1 |
| Kardum, D | 1 |
| Sutlic, Z | 1 |
| Radic, M | 1 |
| Rudez, I | 1 |
| Biocina, B | 1 |
| Roth, BE | 1 |
| Cherian, PT | 1 |
| Cherian, S | 1 |
| Singh, P | 1 |
| Li, GQ | 1 |
| Xia, HH | 1 |
| Tsukamoto, T | 1 |
| Tatematsu, M | 1 |
| Gu, Q | 1 |
| Qiao, L | 1 |
| Cho, CH | 1 |
| So, WH | 1 |
| Yuen, MF | 2 |
| Hu, PJ | 1 |
| Liang, YJ | 1 |
| Lin, HL | 1 |
| Chan, AO | 2 |
| Piazuelo, E | 1 |
| Fuentes, J | 2 |
| García-González, MA | 1 |
| Jiménez, P | 1 |
| Tseng, GY | 1 |
| Lin, HJ | 1 |
| Lanas, AI | 3 |
| Remacha, B | 1 |
| Esteva, F | 2 |
| Sáinz, R | 3 |
| McCarthy, DM | 1 |
| Goebell, H | 1 |
| Holtmann, M | 1 |
| Schubert, TT | 2 |
| Bologna, SD | 2 |
| Nensey, Y | 1 |
| Schubert, AB | 1 |
| Mascha, EJ | 1 |
| Ma, CK | 2 |
| Rabassa, AA | 1 |
| Goodgame, R | 1 |
| Sutton, FM | 1 |
| Ou, CN | 1 |
| Rognerud, C | 1 |
| Bajador, E | 2 |
| Prach, AT | 1 |
| Senior, BW | 1 |
| Hopwood, D | 1 |
| McBride, PD | 1 |
| MacDonald, TM | 1 |
| Kerr, MA | 1 |
| Gambassi, G | 1 |
| Festa, V | 1 |
| Bernabei, R | 1 |
| Dembiński, A | 2 |
| Cullen, DJ | 1 |
| Hawkey, GM | 2 |
| Greenwood, DC | 1 |
| Humphreys, H | 1 |
| Shepherd, V | 1 |
| Logan, RF | 2 |
| Kordecki, H | 1 |
| Kurowski, M | 1 |
| Kosik, R | 1 |
| Pilecka, D | 1 |
| Stachura, J | 2 |
| Hamlet, A | 1 |
| Lindholm, C | 1 |
| Nilsson, O | 1 |
| Olbe, L | 1 |
| Nandurkar, S | 1 |
| Xia, H | 1 |
| Hazel, S | 1 |
| Jones, M | 1 |
| Beales, IL | 1 |
| Zaridze, D | 1 |
| Borisova, E | 1 |
| Maximovitch, D | 1 |
| Chkhikvadze, V | 1 |
| Ishikawa, H | 1 |
| Higaki, M | 2 |
| Matsumoto, Y | 1 |
| Kamimura, T | 1 |
| Katsura, Y | 1 |
| Tomishi, T | 1 |
| Inoue, Y | 1 |
| Takasugi, H | 1 |
| Tomoi, M | 1 |
| Krakowka, S | 1 |
| Yoshida, K | 1 |
| Ng, TM | 1 |
| Fock, KM | 1 |
| Khor, JL | 1 |
| Teo, EK | 1 |
| Sim, CS | 1 |
| Tan, AL | 1 |
| Machin, D | 1 |
| Atherton, JC | 2 |
| Wight, NJ | 1 |
| Hochain, P | 1 |
| Capet, C | 1 |
| Colin, R | 1 |
| Mitobe, Y | 1 |
| Shimada, T | 1 |
| Terano, A | 1 |
| Feldman, M | 2 |
| Shewmake, K | 1 |
| Cryer, B | 3 |
| Akre, K | 2 |
| Signorello, LB | 2 |
| Bergström, R | 1 |
| Larsson, S | 1 |
| Eriksson, BI | 1 |
| Nyrén, O | 2 |
| Russell, RI | 1 |
| Chung, SC | 1 |
| Lee, YT | 1 |
| Leung, VK | 1 |
| Lau, JY | 1 |
| Hui, Y | 1 |
| Lai, MS | 1 |
| Chan, HL | 1 |
| Ekström, AM | 1 |
| Hansson, LE | 1 |
| Fischer, H | 2 |
| Huber, V | 2 |
| Boknik, P | 2 |
| Luess, H | 2 |
| Neumann, J | 2 |
| Brzozowski, T | 1 |
| Schmitz, W | 2 |
| Mallat, D | 1 |
| Go, MF | 1 |
| Verbeek, AL | 1 |
| Jacobson, BC | 1 |
| Voutilainen, M | 1 |
| Mäntynen, T | 1 |
| Juhola, M | 1 |
| Aalykke, C | 1 |
| Lauritsen, K | 1 |
| Slomiany, BL | 1 |
| Piotrowski, J | 1 |
| Slomiany, A | 1 |
| Jones, JI | 1 |
| Peek, RM | 1 |
| Stack, WA | 1 |
| Schmassmann, A | 1 |
| Yoshida, N | 2 |
| Sugimoto, N | 2 |
| Hirayama, F | 1 |
| Naito, Y | 2 |
| Yoshikawa, T | 2 |
| Ochiai, J | 1 |
| Hoshiya, S | 1 |
| Tokunaga, K | 1 |
| Tanaka, A | 1 |
| Nagamatsu, S | 1 |
| Ishida, H | 1 |
| Takahashi, S | 1 |
| Zambrana, JL | 1 |
| Rodríguez-González, FJ | 1 |
| Puente, J | 1 |
| Wildgrube, HJ | 1 |
| Kierschke, G | 1 |
| Nowak, H | 1 |
| Weigmann, I | 1 |
| Terhaag, B | 1 |
| Lai, KC | 1 |
| Lam, SK | 1 |
| Chu, KM | 1 |
| Hui, WM | 1 |
| Hu, WH | 1 |
| Lau, GK | 1 |
| Wong, WM | 1 |
| Lai, CL | 1 |
| Wong, J | 1 |
| Leivonen, M | 1 |
| Kivilaakso, E | 1 |
| Nensey, YM | 1 |
| Evans, DG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Endoscopic Diagnosis, Treatment and Prognosis of Acute Nonvariceal Upper Gastrointestinal Bleeding in Nanchang, Jiangxi Province, China.[NCT04895904] | 3,200 participants (Actual) | Observational | 2014-09-01 | Completed | |||
| Factors Predicting the Need for Endoscopic Intervention in Non-variceal Upper Gastrointestinal Bleeding[NCT05979025] | 262 participants (Actual) | Observational | 2022-08-11 | Completed | |||
| HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction Trial Based on the SWEDEHEART Registry (HELP-SWEDEHEART)[NCT05024864] | 22,000 participants (Anticipated) | Interventional | 2021-11-17 | Recruiting | |||
| HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction Pilot Study[NCT04289012] | 300 participants (Actual) | Interventional | 2019-11-07 | Completed | |||
| Risk of Uncomplicated Peptic Ulcer in the General Population[NCT01888588] | 4,000 participants (Actual) | Observational | 2012-09-30 | Completed | |||
| Falciformopexy for Treatment Perforated Peptic[NCT05715450] | 25 participants (Anticipated) | Interventional | 2023-05-30 | Not yet recruiting | |||
| Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases: A Multicenter, Randomized, Double-blinded, Controlled Trial[NCT03320538] | 360 participants (Anticipated) | Interventional | 2017-07-10 | Recruiting | |||
| Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer[NCT02418312] | 228 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
| Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial[NCT02547012] | 51 participants (Actual) | Interventional | 2013-11-30 | Completed | |||
| Data-driven Quality Improvement in Primary Care: Cluster Randomised Controlled Trial to Test the Effectiveness of a Multifaceted Intervention in Reducing High Risk Prescribing of Non-steroidal Anti-inflammatory Drugs and Antiplatelet Agents[NCT01425502] | 33 participants (Actual) | Interventional | 2012-09-30 | Completed | |||
| Pantoprazole Versus Famotidine for the Prevention of Recurrent Peptic Ulcers in Thienopyridine Users - a Double-blind Randomized Controlled Trial[NCT02551744] | 101 participants (Actual) | Interventional | 2012-07-31 | Completed | |||
| Eradication of Helicobacter Pylori According to 23S rRNA Point Mutations Associated With Clarithromycin Resistance[NCT01453036] | Phase 4 | 924 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)[NCT02741817] | Phase 4 | 20 participants (Actual) | Interventional | 2016-06-26 | Completed | ||
| European Registry on the Management of Helicobacter Pylori Infection[NCT02328131] | 10,000 participants (Anticipated) | Observational | 2013-06-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Follow-up endoscopy was performed at the end of the 6th month (NCT02418312)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Histamine-2 Receptor Antagonist Group | 106 |
| Placebo Group | 101 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02547012)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo+Tetra | 13 |
| Esomeprazole+Amox+Levo | 21 |
Follow-up endoscopy was performed at the end of the 6th month (NCT02551744)
Timeframe: six month
| Intervention | participants (Number) |
|---|---|
| Proton Pump Inhibitor Group | 1 |
| Histamine-2 Receptor Antagonist Group | 7 |
Eradication was determined by the C13-urea breath test 6 to 8 weeks after the eradication therapy when PPIs had not been used for at least 2 weeks. (NCT01453036)
Timeframe: 8 weeks
| Intervention | percentage of participants (Number) |
|---|---|
| Convential AOC Group | 75.9 |
| Mutation Test Group | 91.2 |
| Convential AOM Group | 79.1 |
74 reviews available for aspirin and Infections, Helicobacter
| Article | Year |
|---|---|
A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Humans; Inflammation; Pep | 2023 |
A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Humans; Inflammation; Pep | 2023 |
A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Humans; Inflammation; Pep | 2023 |
A Review on Herbal Drugs Used in the Treatment of Peptic Ulcer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Humans; Inflammation; Pep | 2023 |
Advances in the pharmacotherapeutic management of refractory peptic ulcers.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma | 2023 |
Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of
Topics: Aspirin; Endoscopic Mucosal Resection; Female; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Inf | 2020 |
Prevention of Peptic Ulcer Associated with Aspirin and Antiplatelet Agent.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicobacter Infections; Helico | 2020 |
Management of Peptic Ulcer Bleeding in Patients Taking Aspirin or Anticoagulant.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenal Ulcer; Helicobacter Infec | 2020 |
Non-variceal upper gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Ga | 2018 |
Non-variceal upper gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Ga | 2018 |
Non-variceal upper gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Ga | 2018 |
Non-variceal upper gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Ga | 2018 |
Helicobacter pylori infection and the risk of upper gastrointestinal bleeding in low dose aspirin users: systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Helicobacter Infections; Helicobacter pylori; Humans; Middl | 2018 |
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
Topics: Aspirin; Databases, Bibliographic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; | 2019 |
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
Topics: Aspirin; Databases, Bibliographic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; | 2019 |
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
Topics: Aspirin; Databases, Bibliographic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; | 2019 |
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
Topics: Aspirin; Databases, Bibliographic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; | 2019 |
Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; | 2013 |
[Antithrombotic drug and gastrointestinal injuries].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Fibrinolytic Agents; Gastrointestinal Hemorrhage; | 2013 |
Gastric cancer chemoprevention: the current evidence.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2 Inhibitors | 2013 |
Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Helicobacter Inf | 2014 |
Helicobacter pylori infection in nonsteroidal anti-inflammatory drug users.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma | 2014 |
Epidemiology and diagnosis of acute nonvariceal upper gastrointestinal bleeding.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Duodenal Diseases; Endoscopy, Gastr | 2014 |
Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combi | 2015 |
Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Asia; Aspirin; Australia; Duodenal Ulcer; Duodenum; Europe; | 2015 |
Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Helicobacter Infectio | 2015 |
[Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Membrane Permeability; | 2016 |
Role of Sulforaphane in Protection of Gastrointestinal Tract Against H. pylori and NSAID-Induced Oxidative Stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Mucosa; Gastritis; Gastrointestin | 2017 |
[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal | 2009 |
Systematic review: the global incidence and prevalence of peptic ulcer disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Female; Helicobacter Infections | 2009 |
Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Aspirin; Clopidogrel; Coro | 2009 |
Predicting poor outcome from acute upper gastrointestinal hemorrhage.
Topics: Aging; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Endoscopy, Gastrointestinal; Esophageal and | 2009 |
Differences in peptic ulcer between the East and the West.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug Resistance, Bacterial; Glo | 2009 |
Gastroduodenal mucosal defense.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bicarbonates; Duodenum; Gastric Mucosa; Helicobact | 2009 |
Aspirin use and the risk of gastric cancer: a meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Chi-Square Distribution; | 2010 |
Peptic ulcer disease.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biopsy; Gastroscopy; | 2009 |
Drug-related damage of the ageing gastrointestinal tract.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-St | 2009 |
Optimal management of peptic ulcer disease in the elderly.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; He | 2010 |
Aspirin-induced peptic ulcer and genetic polymorphisms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Aspirin; Cyclooxygenase 1; C | 2010 |
Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Gastrointestinal | 2011 |
Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infectio | 2010 |
[Pathologic characteristics of gastric ulcer in the aged].
Topics: Aged; Aspirin; Helicobacter Infections; Helicobacter pylori; Humans; Stomach Ulcer | 2010 |
[Influence of H. pylori infection on upper gastrointestinal damage].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylor | 2010 |
Gastrointestinal effects of aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Gastric Mucosa; Gastroint | 2011 |
Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cardiovascular Diseas | 2012 |
Helicobacter pylori-negative peptic ulcer. What is its aetiopathogenesis and treatment?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; False Negative Reactions; Helicobacter Infections; | 2002 |
[The future of peptic ulcer disease without Helicobacter].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin | 2003 |
[Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationsh | 2003 |
Non-steroidal anti-inflammatory drug-induced gastroduodenal toxicity and Helicobacter pylori.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Cell Division; Clinical Trials as Topic | 2003 |
[Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Aspirin; Cyclooxygenase Inhi | 2003 |
[Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Gastrointestinal | 2003 |
Usual and unusual causes of duodenal ulcer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Duodenal Ulcer; Helicobacter Infections; Helicobac | 2003 |
Review article: the ageing bowel and intolerance to aspirin.
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Forecasting; Gastrointestinal Disease | 2004 |
Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma | 2004 |
[Role of Helicobacter pylori in drug-induced gastrointestinal bleeding].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relations | 2003 |
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase 2; Decision Maki | 2004 |
Understanding NSAID-PPI-COX-2 interrelationships.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimida | 2004 |
Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cohort Studies; Helicobacter | 2004 |
[Impact of Helicobacter pylori infection on the risk of gastro-duodenal ulcer in patients treated with nonsteroidal antiinflammatory drugs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infectio | 2004 |
[Epidemiology of digestive complications associated with use of low-dose aspirin].
Topics: Aspirin; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Risk Facto | 2004 |
Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; He | 2005 |
Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Diseases; Helicobacter Infections | 2005 |
Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Dyspepsia; Gastrointest | 2005 |
[Relationship between NSAIDs and H. pylori in peptic ulcer diseases--is the eradication of H. pylori recommended in NSAIDs ulcer?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Helicobacter Infections; | 2005 |
Peptic ulcer disease today.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxy | 2006 |
Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Endoscopy, Gastrointestinal; Gastrins; Gastroesoph | 2006 |
Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiova | 2006 |
NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2 Inhibitors; Drug Combinations; Dy | 2006 |
Management of high-risk patients on non-steroidal anti-inflammatory drugs or aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Gastrointestinal Diseases | 2006 |
[Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Gastritis; Gastrointest | 2006 |
Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
Topics: Anti-Ulcer Agents; Aspirin; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; | 2007 |
Iron deficiency in childhood and adolescence: retrospective review.
Topics: Adolescent; Anemia, Iron-Deficiency; Animals; Aspirin; Cattle; Celiac Disease; Child; Child, Prescho | 2006 |
Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiology; Cardiovascular Dise | 2005 |
Strategies to reduce the GI risks of antiplatelet therapy.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cardiova | 2005 |
Maintenance therapy for peptic ulcer--who needs it?
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Helicobacter Infections; Heli | 1993 |
[Digestive complications of aspirin].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Digestive System; | 2000 |
Non-steroidal anti-inflammatory drugs and gastrointestinal damage-problems and solutions.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase Inhibitors | 2001 |
Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Introduction.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase 2; Cyclooxygenas | 2001 |
Management of nonsteroidal anti-inflammatory drug-related peptic ulcer bleeding.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Butanone | 2001 |
Questions regarding future research on aspirin and the gastrointestinal tract.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Delayed-Action | 2001 |
Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Cyclooxygenase I | 2001 |
Epidemiology of NSAID-related gastroduodenal mucosal injury.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc | 2001 |
Gastrointestinal safety of COX-2 specific inhibitors.
Topics: Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygena | 2001 |
23 trials available for aspirin and Infections, Helicobacter
| Article | Year |
|---|---|
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Bacterial Agents; Aspirin; Clarithromycin; Drug Therapy, Combination; Helicobacter; Helic | 2022 |
In older patients receiving aspirin,
Topics: Aged; Aspirin; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Peptic Ulcer; | 2023 |
Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
Topics: Angiography; Aspirin; Breath Tests; Carotid Arteries; Carotid Stenosis; Clopidogrel; Drug Interactio | 2013 |
Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine.
Topics: Adult; Anti-Ulcer Agents; Asian People; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy | 2014 |
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Double-Blind Me | 2009 |
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non- | 2010 |
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non- | 2010 |
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non- | 2010 |
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non- | 2010 |
Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.
Topics: Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Chi-Square Distribution; Drug Therapy, Co | 2012 |
Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer | 2004 |
Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ben | 2004 |
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agent | 2005 |
Effect of high-dose aspirin on Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromyc | 2005 |
Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies | 2006 |
Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer A | 2007 |
Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Aspirin; Cells, Cultured; | 2006 |
Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin.
Topics: Adaptation, Physiological; Adult; Aspirin; Cell Division; DNA; Female; Gastric Mucosa; Gastroscopy; | 1998 |
Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Gastrointestinal | 2000 |
Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Fem | 2000 |
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug The | 2001 |
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agent | 2001 |
Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Topics: Adolescent; Adult; Antibodies, Bacterial; Aspirin; Blood Platelets; Cyclooxygenase 1; Double-Blind M | 2001 |
[Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid afte
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Drug Combinations; Endoscopy; F | 2002 |
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer A | 2002 |
Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
Topics: Adult; Aspirin; Duodenal Ulcer; Duodenum; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Helic | 1991 |
160 other studies available for aspirin and Infections, Helicobacter
| Article | Year |
|---|---|
Accumulation of Deleterious Effects in Gastric Epithelial Cells and Vascular Endothelial Cells In Vitro in the Milieu of
Topics: Antigens, Bacterial; Aspirin; Endothelial Cells; Epithelial Cells; Gastric Mucosa; Helicobacter Infe | 2022 |
Aspirin and Helicobacter pylori interaction.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma | 2022 |
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicoba | 2023 |
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicoba | 2023 |
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicoba | 2023 |
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Helicoba | 2023 |
Helicobacter pylori eradication as a gastroprotective strategy in elderly aspirin-treated subjects: established facts and unanswered questions.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infectio | 2023 |
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months.
Topics: Anti-Bacterial Agents; Aspirin; Coronary Disease; Female; Follow-Up Studies; Helicobacter Infections | 2023 |
Helicobacter pylori eradication and aspirin: a puzzle yet to be solved.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; He | 2023 |
Helicobacter pylori eradication and aspirin: a puzzle yet to be solved - Author's reply.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; He | 2023 |
Should people taking low-dose aspirin have
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; | 2023 |
Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus; Fe | 2019 |
Commentary: cardioprotective aspirin and gastroduodenal ulcers.
Topics: Aspirin; Helicobacter Infections; Humans; Incidence; Peptic Ulcer; Prevalence | 2020 |
Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment.
Topics: Aged; Aged, 80 and over; Aspirin; Female; Gastroscopy; Helicobacter Infections; Histamine H2 Antagon | 2020 |
Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cell Line; Female; Ga | 2021 |
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagula | 2021 |
Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile | 2021 |
Gastric Ulcer Hemorrhage - a Potential Life-Threatening Complication of Intragastric Balloon Treatment of Obesity.
Topics: Adult; Aspirin; Bariatric Surgery; Gastric Balloon; Gastrointestinal Hemorrhage; Helicobacter Infect | 2017 |
Continuing use of antithrombotic medications for patients with bleeding gastroduodenal ulcer requiring endoscopic hemostasis: a case-control study.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Duodenal Ulcer; Duodenum; Female; Fibrinolyt | 2017 |
The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy.
Topics: Aged; Anemia; Aspirin; Atrophy; Causality; Endoscopy, Gastrointestinal; Female; Gastrointestinal Dis | 2017 |
High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.
Topics: Aged; Area Under Curve; Aspirin; Duodenum; Female; Gastrins; Helicobacter Infections; Helicobacter p | 2018 |
Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; CpG | 2017 |
Uninvestigated dyspepsia and associated factors of patients with gastrointestinal disorders in Dessie Referral Hospital, Northeast Ethiopia.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies; | 2018 |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study.
Topics: Adult; Aged; Aspirin; Chemoprevention; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Fe | 2018 |
The Value of Helicobacter Eradication in Long-term Aspirin Users.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter; Helicobacter Infections; Helicobacte | 2018 |
Gastroduodenal ulcer bleeding in elderly patients on low dose aspirin therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cerebrovascu | 2018 |
Low dose aspirin, H. pylori infection, and the risk of upper gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma | 2018 |
Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Comorbidity; Cyclooxygenase | 2019 |
Statins and gastroduodenal endoscopic lesions: A case-control study.
Topics: Adult; Aged; Aspirin; Case-Control Studies; Chi-Square Distribution; Comorbidity; Endoscopy; Female; | 2018 |
Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for
Topics: Adult; Aged; Aspirin; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pyl | 2020 |
Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
Topics: Aged; Aspirin; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Gastrointestinal Diseases; | 2014 |
[HP eradication prevents recurrent hemorrhages caused by acetylsalicylic acid].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cohort Studies; Drug Therapy, C | 2013 |
Relationship between continuous use of low-dose enteric-coated aspirin and gastrointestinal injuries in patients with gastrointestinal hemorrhage.
Topics: Aspirin; Case-Control Studies; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastrointestinal | 2013 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal | 2013 |
Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breath | 2013 |
Testing for the 'ulcer bug' makes daily aspirin safer.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; He | 2013 |
Low-dose aspirin and comorbidities are significantly related to bleeding peptic ulcers in elderly patients compared with nonelderly patients in Japan.
Topics: Adolescent; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, | 2014 |
Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects.
Topics: Aged; Aged, 80 and over; Antibodies, Bacterial; Aspirin; Biomarkers; Drug Administration Schedule; F | 2015 |
Risk factors associated with uncomplicated peptic ulcer and changes in medication use after diagnosis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi | 2014 |
Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Antihyper | 2015 |
Regular aspirin use and stomach cancer risk in China.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Case-Control Studies; China; Fema | 2015 |
Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Female; Helicob | 2015 |
Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Breath Tests; Endoscopy, Gast | 2015 |
Study of Clinical and Genetic Risk Factors for Aspirin-induced Gastric Mucosal Injury.
Topics: Aged; Aspirin; Female; Gastric Mucosa; Genotype; Helicobacter Infections; Humans; Male; Middle Aged; | 2016 |
Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Clinical Decision-M | 2016 |
Effects of low-dose aspirin in subjects with dyslipidemia.
Topics: Adult; Aspirin; C-Reactive Protein; Cholesterol, LDL; Convalescence; Coronary Angiography; Coronary | 2016 |
Etiological Factors in Urgent Gastroduodenal Ulcer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroid | 2015 |
Short-term/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Dinoprostone; Du | 2008 |
Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood.
Topics: Adult; alpha 1-Antitrypsin; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Enzyme-Linked Immunoso | 2008 |
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combina | 2008 |
[Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Duodenal Ulcer; Femal | 2009 |
Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antigens, CD; Aspirin; Cadherins; | 2010 |
Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Agents; En | 2009 |
Guidelines for prevention of NSAID-related ulcer complications.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticoagulants; Aspirin; Cyclooxygenase | 2009 |
Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Dose-Response Relationshi | 2009 |
Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cerebrovascular Dis | 2009 |
NSAIDs and aspirin: notorious or FAMOUS?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase Inhibitors; Esop | 2009 |
Gastroprotective strategy in aspirin users.
Topics: Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hum | 2009 |
[Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Digestive System Diseases; Helicobacter Infections | 2009 |
Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Epidemiologic Methods; Female; Gastric Muco | 2009 |
Predictors of gastroduodenal erosions in patients taking low-dose aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Endoscopy; Femal | 2010 |
[Guidelines of prevention and treatment for NSAID-related peptic ulcers].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticoagulants; Aspirin; Cyclooxygenase | 2009 |
Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breath Tests; | 2010 |
[Pseudoneoplastic regeneration of the stomach. Histopathology and differential diagnosis].
Topics: Aspirin; Carcinoma; Diagnosis, Differential; Gastritis; Helicobacter Infections; Humans; Intestinal | 2010 |
Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biops | 2010 |
[The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aspirin; Child; Drug Therapy, Com | 2010 |
Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study.
Topics: Aged; Aspirin; Cardiovascular Agents; Duodenal Ulcer; Endoscopy, Digestive System; Esophageal Neopla | 2010 |
[Risk factors for development and recurrence of peptic ulcer disease].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Endoscopy, Gastrointestinal; Female; | 2010 |
[Significance of H. pylori eradication in treatment and prevention for low-dose aspirin induced gastric ulcer of elderly].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori | 2010 |
Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy.
Topics: Aged; Aspirin; Endoscopy, Gastrointestinal; Fibrinolytic Agents; Gastric Acid; Gastric Mucosa; Gastr | 2011 |
[The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage].
Topics: Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; | 2011 |
Low-dose aspirin delays gastric healing after Helicobacter pylori eradication.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Female; Gastric Mucosa; Gastritis; Gastrosco | 2011 |
Does long-term aspirin use have any effect on Helicobacter pylori eradication?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti- | 2011 |
A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Comorbidity; Endoscopy, Gastrointestinal; Fe | 2011 |
Anti-platelet therapy and managing ulcer risk.
Topics: Animals; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Combined Modali | 2012 |
New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Helic | 2012 |
Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Aspirin; Case | 2012 |
Correlation between Helicobacter pylori infection and low-dose aspirin use on damage of the upper gastrointestinal tract.
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chi-Square Distributio | 2012 |
Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Acid; Gastrointestinal Diseases; Gastroint | 2012 |
Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level.
Topics: Aged; Aspirin; Drug Administration Schedule; Female; Fibrinolytic Agents; Gastric Acid; Helicobacter | 2012 |
The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Endoscopy; Endoscopy, Gas | 2012 |
Commentary: changing aetiology of peptic ulcers.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Helicobacter Infections; Helicobacter pylo | 2012 |
Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cyclooxygenase 2 Inhibitors; | 2012 |
Letter: are idiopathic (non-NSAID, non-Helicobacter pylori) ulcers really increasing?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Helicobacter Infections; Helicobacter pylo | 2012 |
[Gastrointestinal bleeding associated with NSAIDs, antiplatelet therapy and anticoagulant agent].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Gastrointestinal Hemorrhage; Helic | 2012 |
[Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori].
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Clopid | 2012 |
Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Endoscopy, Gastrointestinal; Female; Gastrointestinal | 2012 |
Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Fibrinolytic Agents; Helicobacter In | 2013 |
Can the diagnosis of NSAID-induced or Hp-associated gastric ulceration be predicted from histology?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Comorbidity; Diagnosis, Differential | 2002 |
Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Drug Administration | 2002 |
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
Correlation between erosive oesophageal and gastro-duodenal diseases. the influence of aspirin, simple analgesics, and Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Duode | 2002 |
Low-dose aspirin: protection from the panacea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2002 |
[A case for proton pump blocker... When cough comes from the stomach].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Age | 2002 |
Effect of H. pylori infection on the expression of cyclooxygenase-2 in human gastric mucosa.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Cyclooxygenase 2; Female; Gastric Mucosa; Helicobacter | 2003 |
Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
Topics: Aspirin; Cardiovascular Diseases; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter | 2003 |
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Barret | 2003 |
Effect of Helicobacter pylori infection and low-dose aspirin use on iron stores in the elderly.
Topics: Aged; Aspirin; Female; Fibrinolytic Agents; Helicobacter Infections; Helicobacter pylori; Humans; Ir | 2003 |
[Heartburn without esophagitis. Symptoms more important than the finding?].
Topics: Androstadienes; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ul | 2003 |
Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factors.
Topics: Adult; Aged; Alcohol Drinking; Aspirin; Cohort Studies; Dyspepsia; Female; Helicobacter Infections; | 2004 |
Helicobacter pylori infection and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose aspirin users: effect of antisecretory drugs.
Topics: Aged; Aspirin; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; | 2004 |
[Helicobacter pylori: changes of indications for eradication therapy].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Drug Therapy, Combination; Gastroesophageal Reflu | 2004 |
Association of aspirin use with vitamin B12 deficiency (results of the BACH study).
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Viral; Aspirin; Biomarkers; | 2004 |
Prevention of aspirin-induced gastroduodenal damage: H. pylori infection eradication versus proton pump inhibitors or both.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Aspirin; Dose-Response Relationship | 2004 |
Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Aspirin; Blotting, Wester | 2004 |
Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breath Tests; Case-Control Studies; D | 2005 |
The appropriate use of proton-pump inhibitor co-therapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Contraindications; Cyclooxygenase Inhibitors; Drug | 2005 |
Definitions and classification of dyspepsia: pH, Helicobacter pylori, non-steroidal anti-inflammatory drugs--should we include gastro-oesophageal reflux disease?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dyspepsia; Gastroesophageal Reflux; Helicobacter I | 2005 |
A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Endoscopy, Gastroi | 2005 |
Protective role of heat shock protein 27 in gastric mucosal injury.
Topics: Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; | 2005 |
[Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
Topics: Age Factors; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer A | 2005 |
Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Duodenum; | 2006 |
Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Attitude of Health Personnel; Cardiot | 2006 |
[Gastric protection and treatment with low-dose aspirin].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; | 2006 |
Frequency of NSAID induced peptic ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclof | 2006 |
[Gastroenterology in family practice. Updates for your "stomach patient"].
Topics: Anti-Ulcer Agents; Aspirin; Clopidogrel; Dyspepsia; Esophagitis, Peptic; Family Practice; Heartburn; | 2006 |
H pylori infection and other risk factors associated with peptic ulcers in Turkish patients: a retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ethano | 2007 |
Gastroduodenal lesions in coronary artery disease patients. Frequency, endoscopic characteristics and risk factors.
Topics: Aspirin; Coronary Disease; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middl | 2007 |
The value of a stretch in the "common era".
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Catheterization; Combined Modal | 2007 |
Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; | 2007 |
[Pathogen eradication prevents gastrointestinal complications].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspi | 2007 |
[Family practice highlights of stomach, liver and intestinal reference points. Your arsenal against abdominal problems].
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Barrett Esophagus; Family Practi | 2007 |
Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Aspirin; Choristoma; Dinoprostone; Epithelial Cells; G | 2008 |
A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
Topics: Aged; Alcohol Drinking; Aspirin; Case-Control Studies; Female; Gastrointestinal Hemorrhage; Gene Fre | 2008 |
Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies; Dyspepsia | 2008 |
Risk factors associated with refractory peptic ulcers.
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Female; Gastric | 1995 |
Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori.
Topics: Adolescent; Adult; Alcohol Drinking; Analgesics; Antibodies, Bacterial; Aspirin; Blood Donors; Colon | 1994 |
Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
Topics: Adult; Age Factors; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Fema | 1993 |
Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose.
Topics: Adult; Aspirin; Biomarkers; Chromatography, High Pressure Liquid; Female; Gastric Mucosa; Gastrointe | 1996 |
Evidence of aspirin use in both upper and lower gastrointestinal perforation.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Helicobacter Infections; Helicobacte | 1997 |
Helicobacter pylori infection status in relation to antibiotic and non-steroidal prescribing in patients on maintenance treatment for chronic duodenal ulcer.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Chroni | 1997 |
Could there be an aspirin good to your stomach?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Helicobacter Infections; Helicobacter pylori; Huma | 1997 |
Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans.
Topics: Adaptation, Physiological; Adult; Aspirin; DNA; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; | 1997 |
Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Female; Helicobacter I | 1997 |
Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Dru | 1997 |
Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.
Topics: Adaptation, Physiological; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dino | 1998 |
Aspirin-induced gastritis, like Helicobacter pylori-induced gastritis disinhibits acid secretion in humans: relation to cytokine expression.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Female; Gastric Acid; Gastric Di | 1998 |
Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Donors; Dyspepsia; Female; Helicobact | 1998 |
Effect of cytokines on acid secretion and gastrin secretion in Helicobacter pylori infection and aspirin-induced gastritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Gastric Acid; Gastrins; Gastri | 1998 |
Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia.
Topics: Adenocarcinoma; Aged; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, | 1999 |
FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Function; D | 1999 |
H. pylori and risk of ulcer bleeding among users of NSAIDS.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infectio | 2000 |
The effects of aspirin on antioxidant defences of cultured rat gastric mucosal cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Cells, Cultured; Dose-Respo | 2000 |
Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Ant | 2000 |
Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; | 2001 |
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.
Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; | 2001 |
Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection.
Topics: Adaptation, Physiological; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Blotti | 2001 |
Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease.
Topics: Aspirin; Calcium Channel Blockers; Deglutition Disorders; Dyspepsia; Fibrinolytic Agents; Flatulence | 2001 |
Preventing upper gastrointestinal bleeding in patients with Helicobacter pylori infection.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastrointestinal Hemorrhage; He | 2001 |
Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dyspepsia; Endoscopy, Digestive System; Fema | 2001 |
The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cost of Illness; Cyclooxy | 2001 |
Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Disease Models, Animal; Gastri | 2001 |
Elimination of Helicobacter pylori or acid in high-risk users of aspirin or nonsteroidal medications: final answer?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Acid; Gastrointestinal Hemorrhage; Helicob | 2002 |
[Long-term prophylaxis with omeprazol is superior to eradication therapy in H. pylori-positive NSAIDs taking patients].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Helicobacter Inf | 2002 |
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Aspirin; Bacterial Protei | 2002 |
Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Female; Gastrointestin | 2002 |
Aspirin injury and H pylori.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gerbillinae; Helicobacter Infections; Hel | 2002 |
Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemotactic Factors; Gastric Mucosa; Gerb | 2002 |
Role of elastase and active oxygen species in gastric mucosal injury induced by aspirin administration in Helicobacter pylori-infected Mongolian gerbils.
Topics: Animals; Aspirin; Catalase; Free Radical Scavengers; Gastric Mucosa; Gerbillinae; Glycine; Helicobac | 2002 |
Helicobacter pylori and acetylsalicylic acid synergistically accelerate apoptosis via Fas antigen pathway in rabbit gastric epithelial cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Apoptosis; Aspirin; Bacterial | 2002 |
[Low-dose of aspirin, gastroprotection and Helicobacter pylori erradication].
Topics: Aged; Aspirin; Helicobacter Infections; Helicobacter pylori; Humans; Platelet Aggregation Inhibitors | 2002 |
Gastric changes in coronary-operated patients with low-dose aspirin.
Topics: Adult; Aged; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Fe | 1992 |
Helicobacter pylori-negative duodenal ulcer.
Topics: Aspirin; Chronic Disease; Duodenal Ulcer; Duodenoscopy; Female; Gastritis; Helicobacter Infections; | 1991 |